To detect anti-SARS-CoV-2 antibodies, we used two commercially available immunoassays: the Roche Elecsys anti-SARS-CoV-2 S and anti-SARS-CoV-2 N immunoassays (Roche Diagnostics, Rotkreuz, Switzerland), which detect immunoglobulins (IgG/A/M) against the receptor binding domain of the virus spike (S) protein (#09 289 275 190, Roche-S) and the virus nucleocapsid (N) protein (#09 203 079 190, Roche-N), respectively. Both assays have high accuracy and have been validated in multiple settings, including our previous serosurveys.20 , 21 (link), 22 (link) We defined seropositivity using the manufacturer's provided cut-off values of titer ≥0.8 U/mL for the Roche-S, and cut-off index ≥1.0 for the Roche-N immunoassays.
Free full text: Click here